How to buy Applied Molecular Transport Inc stock (AMTI)

Applied Molecular Transport Inc is a biotechnology business based in the US. Applied Molecular Transport Inc shares (AMTI) are listed on the NASDAQ and all prices are listed in US Dollars. Applied Molecular Transport Inc employs 13 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Applied Molecular Transport Inc stock

Buy Applied Molecular Transport Inc stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Applied Molecular Transport Inc stock price (NASDAQ: AMTI)

Use our graph to track the performance of AMTI stocks over time.

Applied Molecular Transport Inc shares at a glance

• Key figures

Information last updated 2024-06-30.

52-week range	$0.26 - $0.32
50-day moving average more info button	$0.19
200-day moving average more info button	$0.25
Wall St. target price	$1.00
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-1.89

Is it a good time to buy Applied Molecular Transport Inc stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Applied Molecular Transport Inc financials

Gross profit TTM	$-42,075,000
Return on assets TTM	-51.25%
Return on equity TTM	-158.05%
Profit margin	0%
Book value	$0.40
Market Capitalization more info button	$11 million

TTM: trailing 12 months

Applied Molecular Transport Inc share dividends

We're not expecting Applied Molecular Transport Inc to pay a dividend over the next 12 months.

Applied Molecular Transport Inc share price volatility

Over the last 12 months, Applied Molecular Transport Inc's shares have ranged in value from as little as $0.2603 up to $0.32. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied Molecular Transport Inc's is 2.286. This would suggest that Applied Molecular Transport Inc's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Applied Molecular Transport Inc overview

Applied Molecular Transport Inc. , a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trials to treat patients with chronic pouchitis, as well as is in Phase II development to treat patients with rheumatoid arthritis. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral and respiratory biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California.

Frequently asked questions

null
What percentage of Applied Molecular Transport Inc is owned by insiders or institutions?
Currently 21.357% of Applied Molecular Transport Inc shares are held by insiders and 37.28% by institutions. How many people work for Applied Molecular Transport Inc?
Latest data suggests 13 work at Applied Molecular Transport Inc. When does the fiscal year end for Applied Molecular Transport Inc?
Applied Molecular Transport Inc's fiscal year ends in December. Where is Applied Molecular Transport Inc based?
Applied Molecular Transport Inc's address is: 450 East Jamie Court, South San Francisco, CA, United States, 94080 What is Applied Molecular Transport Inc's ISIN number?
Applied Molecular Transport Inc's international securities identification number is: US03824M1099